skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialopentaosylceramide > alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer

اصطلاح مرجح

alpha-neu5gc-(2->3)-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C62H106N3O37R

جرم

  • 1485.505

جرم تک‌ایزوتوپی

  • 1484.65052

اسمایلٓ

  • O([C@H]1[C@@H]([C@@H](O[C@]2(O[C@]([C@@H]([C@H](C2)O)NC(CO)=O)([C@@H]([C@H](O)CO)O)[H])C(O)=O)[C@H]([C@H](O1)CO)O)O)[C@@H]3[C@H]([C@H](O[C@@H]4[C@H]([C@H](O[C@@H]([C@@H]4O)CO)O[C@@H]5[C@@H]([C@H]([C@@H](O[C@@H]5CO)O[C@H]6[C@@H]([C@H]([C@@H](O[C@@H]6CO)OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*)O)O)O)O)O)O[C@H](CO)[C@@H]3O)NC(C)=O

زیرمجموعه

  • 3_STAR

مترادف دقیق

  • (2S,3R,4E)-2-acylamino-3-hydroxyoctadec-4-en-1-yl 3,5-dideoxy-5-(2-hydroxyacetamido)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

مترادف مرتبط

  • alpha-NeupGc-(2->3)-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
  • NeuGcalpha2->-3Galbeta1->3GalNAcbeta1->3Galalpha1->4Galbeta1->4Glc-Cer
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glc-Cer
  • N-glycoloyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
  • V(3)NeuGcalpha-Gb5Cer

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:142423

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD